LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Netrin-1 Stimulates Migration of Neogenin Expressing Aggressive Melanoma Cells.

    Untiveros, Gustavo / Raskind, Aleksandr / Linares, Laura / Dotti, Alessandro / Strizzi, Luigi

    International journal of molecular sciences

    2022  Volume 23, Issue 21

    Abstract: Netrin-1 is a neural guidance factor that regulates migration and positioning of neural crest-derived cells during embryonic development. Depending on the type of Netrin-1 receptor expression, cells are either attracted or repulsed by Netrin-1. Postnatal ...

    Abstract Netrin-1 is a neural guidance factor that regulates migration and positioning of neural crest-derived cells during embryonic development. Depending on the type of Netrin-1 receptor expression, cells are either attracted or repulsed by Netrin-1. Postnatal expression of Netrin-1 is detected in brain, colon, liver, and kidney, which are common sites of cancer metastasis, including melanoma. Thus, understanding the dynamics between Netrin-1 and its receptors could explain the attraction of melanoma towards these Netrin-1-expressing tissues. Here, we investigate whether the Netrin-1-attractive receptor Neogenin can affect migration of melanoma cells towards a Netrin-1 source. Results from Western blot (WB) analysis show higher expression of Neogenin in aggressive compared to non-aggressive melanoma cells. Cell migration experiments show increased migration of Neogenin-expressing aggressive melanoma cells towards exogenous, soluble recombinant human Netrin-1 and towards a Netrin-1-expressing cell line. Furthermore, WB reveals ERK1/2 activation and increased N-cadherin expression in Neogenin-expressing aggressive melanoma cells treated with rhNetrin-1. Moreover, treatment with anti-Neogenin blocking antibody caused decreased migration towards Netrin-1-expressing cells and reduced ERK1/2 activity in Neogenin-expressing aggressive melanoma cells. These results suggest Neogenin may play a role during migration of melanoma cells towards Netrin-1 via ERK1/2 signaling.
    MeSH term(s) Humans ; Cell Line ; Cell Movement/physiology ; Melanoma/genetics ; Nerve Growth Factors/metabolism ; Netrin-1 ; Transcription Factors
    Chemical Substances Nerve Growth Factors ; Netrin-1 (158651-98-0) ; Transcription Factors
    Language English
    Publishing date 2022-10-22
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms232112751
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Normal Skin Cells Increase Aggressiveness of Cutaneous Melanoma by Promoting Epithelial-to-Mesenchymal Transition via Nodal and Wnt Activity.

    Untiveros, Gustavo / Dezi, Lindsay / Gillette, Megan / Sidor, Julia / Strizzi, Luigi

    International journal of molecular sciences

    2021  Volume 22, Issue 21

    Abstract: Melanoma is a lethal form of skin cancer triggered by genetic and environmental factors. Excision of early-stage, poorly aggressive melanoma often leads to a successful outcome; however, left undiagnosed these lesions can progress to metastatic disease. ... ...

    Abstract Melanoma is a lethal form of skin cancer triggered by genetic and environmental factors. Excision of early-stage, poorly aggressive melanoma often leads to a successful outcome; however, left undiagnosed these lesions can progress to metastatic disease. This research investigates whether the exposure of poorly aggressive melanoma to certain normal skin cells can explain how non-metastatic melanoma becomes more aggressive while still confined to the skin. To this end, we used a serial co-culture approach to sequentially expose cells from two different, poorly aggressive human melanoma cell lines against normal cells of the skin beginning with normal melanocytes, then epidermal keratinocytes, and finally dermal fibroblasts. Protein extraction of melanoma cells occurred at each step of the co-culture sequence for western blot (WB) analysis. In addition, morphological and functional changes were assessed to detect differences between the serially co-cultured melanoma cells and non-co-cultured cells. Results show that the co-cultured melanoma cells assumed a more mesenchymal morphology and displayed a significant increase in proliferation and invasiveness compared to control or reference cells. WB analysis of protein from the co-cultured melanoma cells showed increased expression of Snail and decreased levels of E-cadherin suggesting that epithelial-to-mesenchymal transition (EMT) is occurring in these co-cultured cells. Additional WB analysis showed increased levels of Nodal protein and signaling and signs of increased Wnt activity in the co-cultured melanoma cells compared to reference cells. These data suggest that interaction between poorly aggressive melanoma cells with normal cells of the skin may regulate the transition from localized, poorly aggressive melanoma to invasive, metastatic disease via Nodal and/or Wnt induced EMT.
    MeSH term(s) Cell Line ; Cell Line, Tumor ; Coculture Techniques ; Epithelial-Mesenchymal Transition ; Humans ; Melanoma/metabolism ; Melanoma/pathology ; Nodal Protein/metabolism ; Skin/cytology ; Skin/metabolism ; Skin/pathology ; Skin Neoplasms/metabolism ; Skin Neoplasms/pathology ; Wnt Signaling Pathway ; Melanoma, Cutaneous Malignant
    Chemical Substances NODAL protein, human ; Nodal Protein
    Language English
    Publishing date 2021-10-29
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms222111719
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Role of Presenilin-1 in Aggressive Human Melanoma.

    Sidor, Julia / Gillette, Megan / Dezi, Lindsay Ann / Untiveros, Gustavo / Strizzi, Luigi

    International journal of molecular sciences

    2022  Volume 23, Issue 9

    Abstract: Presenilin-1 (PS-1), a component of the gamma (γ)-secretase catalytic complex, has been implicated in Alzheimer's disease (AD) and in tumorigenesis. Interestingly, AD risk is inversely related to melanoma, suggesting that AD-related factors, such as PS-1, ...

    Abstract Presenilin-1 (PS-1), a component of the gamma (γ)-secretase catalytic complex, has been implicated in Alzheimer's disease (AD) and in tumorigenesis. Interestingly, AD risk is inversely related to melanoma, suggesting that AD-related factors, such as PS-1, may affect melanomagenesis. PS-1 has been shown to reduce Wnt activity by promoting degradation of beta-catenin (β-catenin), an important Wnt signaling partner. Since Wnt is known to enhance progression of different cancers, including melanoma, we hypothesized that PS-1 could affect Wnt-associated melanoma aggressiveness. Western blot results showed that aggressive melanoma cells expressed significantly lower levels of both PS-1 and phosphorylated-β-catenin (P-β-catenin) than nonaggressive melanoma cells. Immunohistochemistry of human melanoma samples showed significantly reduced staining for PS-1 in advanced stage melanoma compared with early stage melanoma. Furthermore, γ-secretase inhibitor (GSI) treatment of aggressive melanoma cells was followed by significant increases in PS-1 and P-β-catenin levels, suggesting impaired Wnt signaling activity as PS-1 expression increased. Finally, a significant reduction in cell migration was associated with the higher levels of PS-1 and P-β-catenin in the GSI-treated aggressive melanoma cells. We demonstrate for the first time that PS-1 levels can be used to assess melanoma aggressiveness and suggest that by enhancing PS-1 expression, Wnt-dependent melanoma progression may be reduced.
    MeSH term(s) Alzheimer Disease ; Amyloid Precursor Protein Secretases/metabolism ; Humans ; Melanoma/genetics ; Melanoma/metabolism ; Presenilin-1/genetics ; Presenilin-1/metabolism ; Wnt Signaling Pathway ; beta Catenin/metabolism
    Chemical Substances Presenilin-1 ; beta Catenin ; Amyloid Precursor Protein Secretases (EC 3.4.-)
    Language English
    Publishing date 2022-04-28
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms23094904
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Structure-based design of small bicyclic peptide inhibitors of Cripto-1 activity.

    Iaccarino, Emanuela / Calvanese, Luisa / Untiveros, Gustavo / Falcigno, Lucia / D'Auria, Gabriella / Latino, Debora / Sivaccumar, Jwala Priyadarsini / Strizzi, Luigi / Ruvo, Menotti / Sandomenico, Annamaria

    The Biochemical journal

    2020  Volume 477, Issue 8, Page(s) 1391–1407

    Abstract: Bicyclic peptides assembled around small organic scaffolds are gaining an increasing interest as new potent, stable and highly selective therapeutics because of their uncommon ability to specifically recognize protein targets, of their small size that ... ...

    Abstract Bicyclic peptides assembled around small organic scaffolds are gaining an increasing interest as new potent, stable and highly selective therapeutics because of their uncommon ability to specifically recognize protein targets, of their small size that favor tissue penetration and of the versatility and easiness of the synthesis. We have here rationally designed bicyclic peptides assembled around a common tri-bromo-methylbenzene moiety in order to mimic the structure of the CFC domain of the oncogene Cripto-1 and, more specifically, to orient in the most fruitful way the hot spot residues H120 and W123. Through the CFC domain, Cripto-1 binds the ALK4 receptor and other protein partners supporting uncontrolled cell growth and proliferation. Soluble variants of CFC have the potential to inhibit these interactions suppressing the protein activity. A CFC analog named B3 binds ALK4 in vitro with an affinity in the nanomolar range. Structural analyses in solution via NMR and CD show that B3 has rather flexible conformations, like the parent CFC domain. The functional effects of B3 on the Cripto-1-positive NTERA cancer cell line have been evaluated showing that both CFC and B3 are cytotoxic for the cells and block the Cripto-1 intracellular signaling. Altogether, the data suggest that the administration of the soluble CFC and of the structurally related analog has the potential to inhibit tumor growth.
    MeSH term(s) Activin Receptors, Type I/genetics ; Activin Receptors, Type I/metabolism ; Amino Acid Motifs ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Drug Design ; GPI-Linked Proteins/antagonists & inhibitors ; GPI-Linked Proteins/chemistry ; GPI-Linked Proteins/genetics ; GPI-Linked Proteins/metabolism ; Humans ; Intercellular Signaling Peptides and Proteins/chemistry ; Intercellular Signaling Peptides and Proteins/genetics ; Intercellular Signaling Peptides and Proteins/metabolism ; Magnetic Resonance Spectroscopy ; Neoplasm Proteins/antagonists & inhibitors ; Neoplasm Proteins/chemistry ; Neoplasm Proteins/genetics ; Neoplasm Proteins/metabolism ; Peptides/chemistry ; Peptides/pharmacology
    Chemical Substances GPI-Linked Proteins ; Intercellular Signaling Peptides and Proteins ; Neoplasm Proteins ; Peptides ; TDGF1 protein, human ; ACVR1B protein, human (EC 2.7.11.30) ; Activin Receptors, Type I (EC 2.7.11.30)
    Language English
    Publishing date 2020-03-09
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2969-5
    ISSN 1470-8728 ; 0006-2936 ; 0306-3275 ; 0264-6021
    ISSN (online) 1470-8728
    ISSN 0006-2936 ; 0306-3275 ; 0264-6021
    DOI 10.1042/BCJ20190953
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The role of Nodal and Cripto-1 in human oral squamous cell carcinoma.

    Daraghma, Hussein / Untiveros, Gustavo / Raskind, Aleksandr / Iaccarino, Emanuela / Sandomenico, Annamaria / Ruvo, Menotti / Arnouk, Hilal / Ciancio, Mae J / Cuevas-Nunez, Maria / Strizzi, Luigi

    Oral diseases

    2020  Volume 27, Issue 5, Page(s) 1137–1147

    Abstract: Oral squamous cell carcinoma (OSCC) is a common epithelial malignancy of the oral cavity. Nodal and Cripto-1 (CR-1) are important developmental morphogens expressed in several adult cancers and are associated with disease progression. Whether Nodal and ... ...

    Abstract Oral squamous cell carcinoma (OSCC) is a common epithelial malignancy of the oral cavity. Nodal and Cripto-1 (CR-1) are important developmental morphogens expressed in several adult cancers and are associated with disease progression. Whether Nodal and CR-1 are simultaneously expressed in the same tumor and how this affects cancer biology are unclear. We investigate the expression and potential role of both Nodal and CR-1 in human OSCC. Immunohistochemistry results show that Nodal and CR-1 are both expressed in the same human OSCC sample and that intensity of Nodal staining is correlated with advanced-stage disease. However, this was not observed with CR-1 staining. Western blot analysis of lysates from two human OSCC line experiments shows expression of CR-1 and Nodal, and their respective signaling molecules, Src and ERK1/2. Treatment of SCC25 and SCC15 cells with both Nodal and CR-1 inhibitors simultaneously resulted in reduced cell viability and reduced levels of P-Src and P-ERK1/2. Further investigation showed that the combination treatment with both Nodal and CR-1 inhibitors was capable of reducing invasiveness of SCC25 cells. Our results show a possible role for Nodal/CR-1 function during progression of human OSCC and that targeting both proteins simultaneously may have therapeutic potential.
    MeSH term(s) Adult ; Carcinoma, Squamous Cell ; Cell Line, Tumor ; Head and Neck Neoplasms ; Humans ; Mouth Neoplasms ; Squamous Cell Carcinoma of Head and Neck
    Language English
    Publishing date 2020-09-25
    Publishing country Denmark
    Document type Journal Article
    ZDB-ID 1290529-x
    ISSN 1601-0825 ; 1354-523X
    ISSN (online) 1601-0825
    ISSN 1354-523X
    DOI 10.1111/odi.13640
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Development of conformational antibodies targeting Cripto-1 with neutralizing effects in vitro.

    Focà, Giuseppina / Iaccarino, Emanuela / Focà, Annalia / Sanguigno, Luca / Untiveros, Gustavo / Cuevas-Nunez, Maria / Strizzi, Luigi / Leonardi, Antonio / Ruvo, Menotti / Sandomenico, Annamaria

    Biochimie

    2019  Volume 158, Page(s) 246–256

    Abstract: Human Cripto-1 (Cripto-1), the founding member of the EGF-CFC superfamily, is a key regulator of many processes during embryonic development and oncogenesis. Cripto-1 is barely present or even absent in normal adult tissues while it is aberrantly re- ... ...

    Abstract Human Cripto-1 (Cripto-1), the founding member of the EGF-CFC superfamily, is a key regulator of many processes during embryonic development and oncogenesis. Cripto-1 is barely present or even absent in normal adult tissues while it is aberrantly re-expressed in various tumors. Blockade of the CFC domain-mediated Cripto-1 functions is acknowledged as a promising therapeutic intervention point to inhibit the tumorigenic activity of the protein. In this work, we report the generation and characterization of murine monoclonal antibodies raised against the synthetic folded CFC [112-150] domain of the human protein. Through subtractive ELISA assays clones were screened for the ability to specifically recognize "hot spot" residues on the CFC domain, which are crucial for the interaction with Activin Type I receptor (ALK4) and GRP78. On selected antibodies, SPR and epitope mapping studies have confirmed their specificity and have revealed that recognition occurs only on a conformational epitope. Furthermore, FACS analyses have confirmed the ability of 1B4 antibody to recognize the membrane-anchored and soluble native Cripto-1 protein in a panel of human cancer cells. Finally, we have evaluated its functional effects through in vitro cellular signaling assays and cell cycle analysis. These findings suggest that the selected anti-CFC mAbs have the potential to neutralize the protein oncogenic activity and may be used as theranostic molecules suitable as tumor homing agents for Cripto-1-overexpressing cancer cells and tissues and to overcome drug-resistance in routine cancer therapies.
    MeSH term(s) Activin Receptors, Type I/immunology ; Activin Receptors, Type I/metabolism ; Animals ; Antibodies, Monoclonal, Murine-Derived/chemistry ; Antibodies, Monoclonal, Murine-Derived/immunology ; Antibodies, Neoplasm/chemistry ; Antibodies, Neoplasm/immunology ; Antibodies, Neutralizing/chemistry ; Antibodies, Neutralizing/immunology ; Cell Line, Tumor ; Flow Cytometry ; GPI-Linked Proteins/immunology ; GPI-Linked Proteins/metabolism ; Heat-Shock Proteins/immunology ; Heat-Shock Proteins/metabolism ; Humans ; Intercellular Signaling Peptides and Proteins/immunology ; Intercellular Signaling Peptides and Proteins/metabolism ; Mice ; Mice, Inbred BALB C ; Neoplasm Proteins/immunology ; Neoplasm Proteins/metabolism ; Protein Domains
    Chemical Substances Antibodies, Monoclonal, Murine-Derived ; Antibodies, Neoplasm ; Antibodies, Neutralizing ; GPI-Linked Proteins ; Heat-Shock Proteins ; Intercellular Signaling Peptides and Proteins ; Neoplasm Proteins ; TDGF1 protein, human ; ACVR1B protein, human (EC 2.7.11.30) ; Activin Receptors, Type I (EC 2.7.11.30) ; molecular chaperone GRP78 (YCYIS6GADR)
    Language English
    Publishing date 2019-01-28
    Publishing country France
    Document type Journal Article
    ZDB-ID 120345-9
    ISSN 1638-6183 ; 0300-9084
    ISSN (online) 1638-6183
    ISSN 0300-9084
    DOI 10.1016/j.biochi.2019.01.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Micro-RNA-195 and -451 regulate the LKB1/AMPK signaling axis by targeting MO25.

    Chen, Hao / Untiveros, Gustavo M / McKee, Laurel A K / Perez, Jessica / Li, Jing / Antin, Parker B / Konhilas, John P

    PloS one

    2012  Volume 7, Issue 7, Page(s) e41574

    Abstract: Background: Recently, MicroRNAs (miR) and AMP-kinase (AMPK) have emerged as prominent players in the development of cardiac hypertrophy and heart failure. We hypothesized that components of the adenosine monophosphate-activated kinase (AMPK) pathway are ...

    Abstract Background: Recently, MicroRNAs (miR) and AMP-kinase (AMPK) have emerged as prominent players in the development of cardiac hypertrophy and heart failure. We hypothesized that components of the adenosine monophosphate-activated kinase (AMPK) pathway are targeted by miRs and alter AMPK signaling during pathological cardiac stress.
    Methodology/principal findings: Using a mouse model of hypertrophic cardiomyopathy (HCM), we demonstrated early elevation of miR-195 and miR-451 in HCM hearts, which targets MO25, a central component of the MO25/STRAD/LKB1 complex that acts as an upstream kinase for AMPK. We show functional targeting of MO25 by miR-195 and -451. Further in vitro interrogation of MO25 as a functional target validated this hypothesis where over-expression of miR-195 in C2C12 cells knocked down MO25 expression levels and downstream AMPK signaling (phosphorylation of Acetyl CoA carboxylase [ACC] and AMPK activity assay), similar to MO25 knockdown in C2C12 cells by siRNA. Parallel changes were measured in 60 day R403Q HCM male hearts that were rescued by short-term administration of AICAR, an AMPK agonist.
    Conclusions/significance: Elevated miR-195 targets the LKB1/AMPK signaling axis in HCM progression and implicates a functional role in HCM disease progression. MiR-195 may serve as potential therapeutics or therapeutic targets for heart disease.
    MeSH term(s) Adaptor Proteins, Signal Transducing/genetics ; Adaptor Proteins, Signal Transducing/metabolism ; Adenylate Kinase/metabolism ; Animals ; Base Sequence ; Calcium-Binding Proteins ; Cardiomyopathy, Hypertrophic/drug therapy ; Cardiomyopathy, Hypertrophic/genetics ; Cardiomyopathy, Hypertrophic/metabolism ; Cardiomyopathy, Hypertrophic/pathology ; Cell Line ; Disease Progression ; Enzyme Activation/genetics ; Humans ; Male ; Mice ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Molecular Targeted Therapy ; Myocardium/metabolism ; Myocardium/pathology ; Organ Specificity ; Protein-Serine-Threonine Kinases/metabolism ; Signal Transduction/genetics ; Up-Regulation/genetics
    Chemical Substances Adaptor Proteins, Signal Transducing ; Cab39 protein, mouse ; Calcium-Binding Proteins ; MIRN195 microRNA, mouse ; MicroRNAs ; Mirn451 microRNA, mouse ; Stk11 protein, mouse (EC 2.7.1.-) ; Protein-Serine-Threonine Kinases (EC 2.7.11.1) ; Adenylate Kinase (EC 2.7.4.3)
    Language English
    Publishing date 2012-07-23
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0041574
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top